Sector revisions Cardiol Therapeutics Inc.

Stocks

Market Closed - Toronto S.E. 00:00:00 16/09/2026 +04			5-day change	1st Jan Change
2.580 ^CAD	-6.86%		-15.69%	+96.95%

08-13	Cardiol Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-12	Cardiol Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
CARDIOL THERAPEUTICS INC.		2
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		20
IQVIA HOLDINGS INC.		18
BEONE MEDICINES AG		28
CELLTRION, INC.		22
ASCENDIS PHARMA A/S	-	20
MEDPACE HOLDINGS, INC.		12
EUROFINS SCIENTIFIC SE		14
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		14
ICON PUBLIC LIMITED COMPANY		16
BIO-TECHNE CORPORATION		11
TEMPUS AI, INC.		17
ABIVAX		7
PHARMARON BEIJING CO., LTD.		11
PROTAGONIST THERAPEUTICS, INC.		13
KYMERA THERAPEUTICS, INC.		22
PRAXIS PRECISION MEDICINES, INC.		19
GENSCRIPT BIOTECH CORPORATION		7
IONIS PHARMACEUTICALS, INC.		21
Average		16
Weighted average by Cap.		19

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!